Summary
- Current Price
- As of today, BBOT price is $4.95, down -10.33% on
- Current Price All-Time High
- BBOT price is currently -66.71% below its historical high of $14.87 set on
- Market Cap
- BBOT current market cap is $397M, up +65.99% over the past 365 days
- Revenue
- BBOT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for BBOT is on
Profile
| Metric | Value |
|---|---|
| Full Name | BridgeBio Oncology Therapeutics, Inc. |
| Ticker | NASDAQ: BBOT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bbotx.com |
| Employees | 62 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $4.95 | |
| Price, 1D Change | -10.33% | |
| $397M | ||
| - | ||
| - | ||
| 1.53 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.30 | ||
| EPS, 1Y Change | +99.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | HLXB | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$4.30 | ||
| EPS Estimate | -$2.85 | N/A |
| EPS Est. Change | +33.89% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $4.95 | |
| Price Target | $22.00 | - |
| Price Tgt. Change | +344.44% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$5,756.41 | - | |
| -$3.03 | -$4.30 | -41.98% | |
| -$2.85 | N/A | +33.89% | |
| -$2.72 | N/A | +36.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $4.95 | |
| $9.65 | ||
| $8.64 | ||
| $9.27 | ||
| $8.46 | ||
| -$0.61 | ||
| 1.53 | ||
| $0.67 | ||
| 16.84 | ||
| 142.08% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$4.30 | ||
| -$610.00K | ||
| - | ||
| -$145.82M | ||
| - | ||
| -$134.04M | ||
| - | ||
| -$145.21M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 12.34 | ||
| 12.34 | ||
| - | ||
| - | ||
| 5.15 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.23 | ||
| -0.88 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $411.10M | ||
| $425.46M | ||
| $449.08M | ||
| $432.40M | ||
| $37.99M | ||
| $35.04M | ||
| $2.77M | ||
| $522.00K | ||
| $1.37M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $134.04M | ||
| $145.21M | ||
| $610.00K | ||
| $0.00 | ||
| $610.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$113.89M | ||
| $73.33M | ||
| $383.40M | ||
| $606.00K | ||
| -$114.50M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Leerink Partners | → | |
| Wedbush | → | |
| Stifel | → | |
| Raymond James | → | |
| Canaccord Genuity | → | |
| JP Morgan | → | |
| JP Morgan | ||
| Canaccord Genuity | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with BBOT
FAQ
- What is the ticker symbol for BridgeBio Oncology Therapeutics, Inc.?
- The ticker symbol for BridgeBio Oncology Therapeutics, Inc. is NASDAQ:BBOT
- Does BridgeBio Oncology Therapeutics, Inc. pay dividends?
- No, BridgeBio Oncology Therapeutics, Inc. does not pay dividends
- What sector is BridgeBio Oncology Therapeutics, Inc. in?
- BridgeBio Oncology Therapeutics, Inc. is in the Healthcare sector
- What industry is BridgeBio Oncology Therapeutics, Inc. in?
- BridgeBio Oncology Therapeutics, Inc. is in the Biotechnology industry
- What country is BridgeBio Oncology Therapeutics, Inc. based in?
- BridgeBio Oncology Therapeutics, Inc. is headquartered in United States
- When did BridgeBio Oncology Therapeutics, Inc. go public?
- BridgeBio Oncology Therapeutics, Inc. initial public offering (IPO) was on August 12, 2025
- Is BridgeBio Oncology Therapeutics, Inc. in the S&P 500?
- No, BridgeBio Oncology Therapeutics, Inc. is not included in the S&P 500 index
- Is BridgeBio Oncology Therapeutics, Inc. in the NASDAQ 100?
- No, BridgeBio Oncology Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is BridgeBio Oncology Therapeutics, Inc. in the Dow Jones?
- No, BridgeBio Oncology Therapeutics, Inc. is not included in the Dow Jones index
- When was BridgeBio Oncology Therapeutics, Inc. last earnings report?
- BridgeBio Oncology Therapeutics, Inc.'s most recent earnings report was on August 11, 2026
- When does BridgeBio Oncology Therapeutics, Inc. report earnings?
- The next expected earnings date for BridgeBio Oncology Therapeutics, Inc. is November 11, 2026
Data Sources & References
- BBOT Official Website bbotx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1869105/000119312526094112/0001193125-26-094112-index.htm
- BBOT Profile on Yahoo Finance finance.yahoo.com/quote/BBOT
- BBOT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bbot